Is CJC-1295 / Ipamorelin from Lumera Labs HPLC verified?

Yes. Every CJC-1295 / Ipamorelin lot Lumera Labs ships is HPLC-purity tested at synthesis and retested by Janoshik Analytical before release. The lot-specific Certificate of Analysis is published on the Lab Results page.

Is CJC-1295 / Ipamorelin sold for human use?

No. CJC-1295 / Ipamorelin is sold strictly as a laboratory reference standard for in-vitro research. It is not approved by Health Canada or the FDA for human use. Every order requires a research-use declaration.

How is CJC-1295 / Ipamorelin shipped?

CJC-1295 / Ipamorelin is lyophilized at synthesis, sealed under nitrogen, and shipped from Kelowna, BC at -20 C through cold-chain insulated packaging via Canada Post Xpresspost. Free shipping over $200 CAD. 24-48h transit Canada-wide.

Where can I see the COA for CJC-1295 / Ipamorelin?

Each shipment includes a lot-specific Certificate of Analysis. The current lot's COA is also published at https://lumerapeptide.com/lab-results/ and can be cross-referenced by the batch number printed on each vial.

Home / Catalog / Growth Axis / CJC-1295 / Ipamorelin 10 mg

4.9 · 258 researcher reviews

Growth axis · GHRH + GHS pre-blend

CJC-1295 / Ipamorelin

SKU LUM-CJCIPA-10 · Pre-blend · Mixed (3367.93 + 711.86 g/mol) · CAS Mixed (863288-34-0 / 170851-70-4)

A pre-blended GHRH-analog plus selective ghrelin-receptor agonist. Co-lyophilized for synergistic-pulse GH-axis research protocols.

Purity (HPLC): ≥ 99.34%
Net peptide: 5.00 mg ± 2%
Endotoxin: < 0.5 EU/mg
Format: Lyophilized vial
Storage: −20 °C, desiccated
Shelf life: 24 months from MFG

$100CAD / 10 mg vial

In stock · Lot 26-A031

Bulk 10+: $24 / vial

Add $200 for free cold-chain shipping

HPLC + MS verified per lot
Cold-chain to your door
COA bundled with shipment
Lot retains kept 5 years

Overview

CJC-1295 / Ipamorelin pairs a 30-residue GHRH(1-29) analog with a 5-residue selective growth-hormone secretagogue (ghrelin-receptor agonist). The two mechanisms are studied in parallel for synergistic pulsatile GH release in cell-culture and rodent models.

Each component meets ≥ 99% HPLC purity independently before co-lyophilization. Vials are sealed under nitrogen and shipped cold-chain at −20 °C from our Kelowna facility.

Research applications

Synergistic GHRH-R + GHS-R activation studies, pituitary GH-secretion potentiation assays, and comparative pulsatile-release pharmacokinetics versus CJC-1295 or Ipamorelin alone.

Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.

Identity

Parameter	Value
Sequence	CJC-1295 (no DAC) + Ipamorelin
Molecular formula	Pre-blend
Molecular weight	Mixed (3367.93 + 711.86 g/mol)
CAS number	Mixed (863288-34-0 / 170851-70-4)
Length	Pre-blend (30 + 5 residues)

Quality

Test	Specification
HPLC purity	≥ 99.0% (lot LM-2615: ≥ 99.0% per component)
Mass confirmation	ESI-MS within 0.5 Da
Net peptide content	≥ 80% by AAA
Endotoxin	< 0.5 EU/mg (LAL)
Bioburden	< 10 CFU/g
Residual TFA	< 1.0%

Lot LM-2615

Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.

Verification

Method	Result
RP-HPLC at 220 nm	≥ 99.0% per component main peak
ESI-MS (positive)	Two peaks: 3367.9 + 711.9 Da
Amino acid analysis	82.1% net peptide
LAL endotoxin	< 0.05 EU/mg
Karl Fischer (water)	2.8% w/w

Reconstitution

Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.

Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.

Storage after reconstitution

Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.